Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, +49

New England Journal of Medicine

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, +123

The Lancet

Hematological MalignancyMedicineImmunologyHematologyPharmacotherapy +4

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro, +69

The Lancet Oncology

Hematological MalignancyOncologyDexamethasone Versus PomalidomideMetronomic TherapyImmunology +5

Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene

Fransiska Malfait, Delfien Syx, Philip Vlummens, +5

Human Mutation

Eds Vib PhenotypeGeneticsThumb Clubfoot SyndromeGenetic EpidemiologyPathology +17

Comprehensive Clinical and Molecular Analysis of 12 Families with Type 1 Recessive Cutis Laxa

Bert Callewaert, Chi-Ting Su, Tim Van Damme, +25

Human Mutation

Inflammatory Lung DiseaseLung InflammationRecessive Cutis LaxaGeneticsGenetic Epidemiology +20

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

Kim De Veirman, Eline Menu, Ken Maes, +11

Cancer Letters

Hematological MalignancyAmpk PathwayMalignant Blood DisorderMyeloid-derived Suppressor CellsCell Death +8

The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma

Sylvia Faict, Inge Oudaert, Ludovic D’Auria, +11

Cancers

Chemoprevention StrategyImmunologyPathologyTumor BiologyMyeloid Neoplasia +15

Subgroup analysis of ICARIA‐MM study in relapsed/refractory multiple myeloma patients with high‐risk cytogenetics

Simon J. Harrison, Aurore Perrot, Adrían Alegre, +15

British Journal of Haematology

A Novel Splice Variant in the N-propeptide of COL5A1 Causes an EDS Phenotype with Severe Kyphoscoliosis and Eye Involvement

Sofie Symoens, Fransiska Malfait, Philip Vlummens, +3

PLoS ONE

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial

Monique C. Minnema, Kazem Nasserinejad, Bouke P. C. Hazenberg, +16

Haematologica